Cellular Technology LIMITED

Shaker Heights, OH

UEI
J4NPKD56Q3K8
CAGE
1VGK8
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Manufacturer of Goods
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
20521 Chagrin Blvd, Shaker Heights, OH 44122, USA
Website
immunospot.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $47,525
FY2025 $53,170

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Veterans Affairs $47,525

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Cellular Technology LIMITED, a self-certified small disadvantaged business manufacturer of analytical laboratory instruments, operates as a prime contractor selling specialized laboratory analyzers and consumables to federal health and defense agencies, with 83 total awards spanning two decades and a concentrated recent footprint in National Institutes of Health procurement. The vendor competes in full-and-open procurements rather than set-aside vehicles; recent awards carry no set-aside designation despite the vendor's small disadvantaged business profile.

Cellular Technology LIMITED manufactures and supplies analytical laboratory instruments, principally ELISPOT readers and related laboratory consumables. The vendor's core capability is represented by recent purchases including a CTL ImmunoSpot S6 Ultra M2 Analyzer ($47,525) awarded to Veterans Integrated Service Network 15 on July 27, 2026, under FAR Part 12 commercial authority as a sole-source acquisition; a CTL ImmunoSpot S6 Entry Analyzer procured by the Food and Drug Administration on September 2, 2026; and FDA procurement of DARS laboratory supplies and consumables ($53,170) awarded August 12, 2025. All three recent awards are firm fixed-price purchase orders reflecting the vendor's product-sales posture rather than service delivery.

Customer concentration is extreme and skewed toward HHS and the National Institutes of Health. The National Institutes of Health National Institute of Allergy and Infectious Diseases DEA OA Acquisitions dominates both dollars and strategic value, anchoring 7 awards worth $80.2 million combined potential value — 88% of the vendor's total $90.8 million combined potential across all awards. The top five customer entities account for 54% of total awards by count but 99% of combined potential value. The Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services (15 awards), the Department of the Navy Bureau of Medicine and Surgery (9 awards), and the National Institutes of Health (8 awards) round out the active set.

The vendor sits on an Indefinite Delivery Contract (HHSN266200400098I) carrying two task orders and $89 million combined potential value, representing the majority of its pipeline. Activity shows a long tail — ten awards in 2010, five in 2011, two in 2012 — followed by a gap until 2025–2026, when one award arrived in 2025 and two in 2026. Only one award ($48 thousand) reaches ultimate completion inside the next twenty-four months, indicating minimal near-term recompete exposure. Combined dollars obligated stand at $14.3 million (16% of combined potential value), signaling that much of the vendor's pipeline carries unexecuted ceiling values. Cellular Technology operates exclusively as a prime (100% of awards) with no subcontractor relationships in the federal space. The vendor is headquartered in Shaker Heights, Ohio, and serves as a manufacturer of analytical laboratory instruments under primary NAICS 325414 (In-Vitro Diagnostic Substance Manufacturing) and related instrument repair and maintenance categories.

Quick answers

Is Cellular Technology LIMITED registered in SAM.gov?

Yes. Cellular Technology LIMITED's SAM.gov registration is active through April 21, 2027.

How much has Cellular Technology LIMITED received in federal contracts?

Federal contracts obligated $53,170 to Cellular Technology LIMITED in fiscal year 2025 and $100,695 in fiscal years 2023 through 2027.

What is Cellular Technology LIMITED's most recent federal award?

Cellular Technology LIMITED's most recent federal contract award is EO 14398 CTL immunospot S6 entry analyzer (elispot reader) (75F40126P00239), from Food and Drug Administration, on September 2, 2026.

On GovTribe

See Cellular Technology LIMITED's full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors